Cargando…

MYC dysfunction modulates stemness and tumorigenesis in breast cancer

As a transcription factor and proto-oncogene, MYC is known to be deregulated in a variety of tumors, including breast cancer. However, no consistent conclusion on the role and mechanism of MYC deregulation during breast cancer carcinogenesis has been formed. Here, we used the UALCAN, bc-GenExMiner,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yiqiu, Zhu, Chengjun, Tang, Lin, Chen, Qin, Guan, Nan, Xu, Kun, Guan, Xiaoxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757029/ https://www.ncbi.nlm.nih.gov/pubmed/33390842 http://dx.doi.org/10.7150/ijbs.51458

Ejemplares similares

Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer
por: Li, Xintong, et al.
Publicado: (2022)

Cuproptosis engages in c-Myc-mediated breast cancer stemness
por: Wang, Runtian, et al.
Publicado: (2023)

SOX9 interacts with FOXC1 to activate MYC and regulate CDK7 inhibitor sensitivity in triple-negative breast cancer
por: Tang, Lin, et al.
Publicado: (2020)

Expression of CDK7 correlates with molecular subtypes and predicts clinical outcomes in breast cancer
por: Tang, Lin, et al.
Publicado: (2021)

A six-gene signature related with tumor mutation burden for predicting lymph node metastasis in breast cancer
por: Wang, Cenzhu, et al.
Publicado: (2021)

Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors
por: Yang, Fang, et al.
Publicado: (2016)

Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis
por: Xu, Kun, et al.
Publicado: (2021)

C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC
por: Chen, Xiyan, et al.
Publicado: (2017)

c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis
por: Ji, Wenfei, et al.
Publicado: (2020)

Microenvironment components and spatially resolved single-cell transcriptome atlas of breast cancer metastatic axillary lymph nodes: The lymph node atlas of breast cancer metastases
por: Xu, Kun, et al.
Publicado: (2022)

HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity
por: Zhang, Chen, et al.
Publicado: (2017)

SIX1 amplification modulates stemness and tumorigenesis in breast cancer
por: Guo, Liantao, et al.
Publicado: (2023)

EI24 Suppresses Tumorigenesis in Pancreatic Cancer via Regulating c-Myc
por: Zang, Yi, et al.
Publicado: (2018)

The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)

Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer
por: Wang, Jiayang, et al.
Publicado: (2020)

c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment
por: Gao, Fang-yan, et al.
Publicado: (2023)

Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis
por: Moumen, Mejdi, et al.
Publicado: (2013)

Curcumin suppresses tumorigenesis by ferroptosis in breast cancer
por: Cao, Xuelei, et al.
Publicado: (2022)

Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer
por: Wang, Cenzhu, et al.
Publicado: (2021)

Circadian Gene cry Controls Tumorigenesis through Modulation of Myc Accumulation in Glioblastoma Cells
por: Jarabo, Patricia, et al.
Publicado: (2022)

Germline Mutations in Mtap Cooperate with Myc to Accelerate Tumorigenesis in Mice
por: Kadariya, Yuwaraj, et al.
Publicado: (2013)

Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines
por: Pajuelo-Lozano, Natalia, et al.
Publicado: (2020)

Developmental Context Determines Latency of MYC-Induced Tumorigenesis
por: Beer, Shelly, et al.
Publicado: (2004)

SSR2 overexpression associates with tumorigenesis and metastasis of Hepatocellular Carcinoma through modulating EMT
por: Hong, Xiaopeng, et al.
Publicado: (2020)

Combined Androgen receptor blockade overcomes the resistance of breast cancer cells to palbociclib
por: Ji, Wenfei, et al.
Publicado: (2019)

Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
por: Peng, Fu, et al.
Publicado: (2017)

The long non‐coding RNA landscape in triple‐negative breast cancer
por: Zhang, Wenwen, et al.
Publicado: (2020)

MYC overexpression with its prognostic and clinicopathological significance in breast cancer
por: Qu, Jingkun, et al.
Publicado: (2017)

Mnt modulates Myc-driven lymphomagenesis
por: Campbell, Kirsteen J, et al.
Publicado: (2017)

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
por: Dhanasekaran, Renumathy, et al.
Publicado: (2017)

Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro
por: Li, Qinghua, et al.
Publicado: (2016)

MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state
por: Poli, Vittoria, et al.
Publicado: (2018)

A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma
por: Wang, Dong, et al.
Publicado: (2021)

BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis
por: Richart, Laia, et al.
Publicado: (2016)

Do changes in the c-MYC coding sequence contribute to tumorigenesis?
por: Chakraborty, Abhishek A., et al.
Publicado: (2014)

Cancer stem cells and tumorigenesis
por: Zhu, Pingping, et al.
Publicado: (2018)

Author Correction: Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
por: Peng, Fu, et al.
Publicado: (2023)

3′ untranslated region 1630 C>T polymorphism of prohibitin increases risk of breast cancer
por: Tang, Lin, et al.
Publicado: (2013)

Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer
por: Ali, Amjad, et al.
Publicado: (2021)

Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment
por: Yu, Ya-Nan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_85ikjplbtb0suk8vm0s2hjffhl